• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

美国农村地区基于办公室的阿片类药物治疗中的障碍。

Barriers in Office-Based Opioid Treatment in Rural United States.

作者信息

Satyasi Savitha K, Stewart Christopher, Parimi Kaushal, Sukpraprut-Braaten Suporn, Ashraf Nauman

机构信息

Psychiatry, Freeman Health System, Joplin, USA.

Medical School, Kansas City University of Medicine and Biosciences, Joplin, USA.

出版信息

Cureus. 2024 Nov 10;16(11):e73373. doi: 10.7759/cureus.73373. eCollection 2024 Nov.

DOI:10.7759/cureus.73373
PMID:39664135
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11633845/
Abstract

Background The opioid crisis has severely impacted health outcomes in the United States, particularly in rural areas, where barriers to medication-based treatment for opioid use disorder (OUD) persist. Although medication-assisted treatment (MAT) for OUD is effective, access remains limited, especially in these communities. Aim This study identifies and examines barriers to accessing office-based OUD treatment in rural areas of the United States. Methods We conducted a cross-sectional survey of 49 adults with OUD treated at an outpatient facility in rural Missouri. The survey assessed familiarity with OUD medications, barriers to accessing treatment, difficulties finding providers, and support systems. Data were analyzed using descriptive statistics and chi-square tests to compare accessibility and emotional barriers. Results The primary barriers identified were related to accessibility (54%), including costs, insurance, clinic hours, and transportation, significantly outweighing emotional barriers like stigma or lack of support (26%). Accessibility barriers were notably higher than cases reporting no barriers (p<0.01) and higher than those who reported emotional barriers (p<.05). This highlights the need for improved infrastructure and support. Conclusion Cost, insurance, clinic location, and limited clinic hours are significant obstacles to OUD treatment in rural areas. Addressing these barriers through strategies like expanded clinic hours, telehealth, transportation assistance, and physician education is essential to improving access to care for OUD patients in rural settings.

摘要

背景

阿片类药物危机严重影响了美国的健康状况,尤其是在农村地区,那里针对阿片类药物使用障碍(OUD)的药物治疗障碍依然存在。尽管针对OUD的药物辅助治疗(MAT)是有效的,但获取途径仍然有限,尤其是在这些社区。

目的

本研究识别并调查了美国农村地区获得门诊OUD治疗的障碍。

方法

我们对在密苏里州农村一家门诊机构接受治疗的49名患有OUD的成年人进行了横断面调查。该调查评估了对OUD药物的熟悉程度、获得治疗的障碍、寻找提供者的困难以及支持系统。使用描述性统计和卡方检验分析数据,以比较可及性障碍和情感障碍。

结果

确定的主要障碍与可及性有关(54%),包括成本、保险、诊所营业时间和交通,大大超过了耻辱感或缺乏支持等情感障碍(26%)。可及性障碍明显高于报告无障碍的情况(p<0.01),也高于报告情感障碍的情况(p<.05)。这凸显了改善基础设施和支持的必要性。

结论

成本、保险、诊所位置和有限的诊所营业时间是农村地区OUD治疗的重大障碍。通过延长诊所营业时间、远程医疗、交通援助和医生教育等策略来解决这些障碍,对于改善农村地区OUD患者获得医疗服务至关重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/97da/11633845/6bb066e2f26c/cureus-0016-00000073373-i03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/97da/11633845/0bdf2e9a3e1a/cureus-0016-00000073373-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/97da/11633845/beb047f069a4/cureus-0016-00000073373-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/97da/11633845/6bb066e2f26c/cureus-0016-00000073373-i03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/97da/11633845/0bdf2e9a3e1a/cureus-0016-00000073373-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/97da/11633845/beb047f069a4/cureus-0016-00000073373-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/97da/11633845/6bb066e2f26c/cureus-0016-00000073373-i03.jpg

相似文献

1
Barriers in Office-Based Opioid Treatment in Rural United States.美国农村地区基于办公室的阿片类药物治疗中的障碍。
Cureus. 2024 Nov 10;16(11):e73373. doi: 10.7759/cureus.73373. eCollection 2024 Nov.
2
Strategies to recruit rural primary care providers to implement a medication for opioid use disorder (MOUD) focused integrated care model.招募农村初级保健提供者以实施专注于阿片类药物使用障碍药物治疗(MOUD)的综合护理模式的策略。
Implement Res Pract. 2023 Feb 19;4:26334895231152808. doi: 10.1177/26334895231152808. eCollection 2023 Jan-Dec.
3
Rural access to MAT in Pennsylvania (RAMP): a hybrid implementation study protocol for medication assisted treatment adoption among rural primary care providers.宾夕法尼亚州农村获取 MAT(RAMP):一项混合实施研究方案,旨在促进农村初级保健提供者采用药物辅助治疗。
Addict Sci Clin Pract. 2019 Aug 1;14(1):25. doi: 10.1186/s13722-019-0154-4.
4
The Role of Primary Care in Improving Access to Medication-Assisted Treatment for Rural Medicaid Enrollees with Opioid Use Disorder.初级保健在改善农村医疗补助计划参保者阿片类药物使用障碍患者获得药物辅助治疗方面的作用。
J Gen Intern Med. 2019 Jun;34(6):936-943. doi: 10.1007/s11606-019-04943-6. Epub 2019 Mar 18.
5
Perceived Ability to Treat Opioid Use Disorder in West Virginia.西弗吉尼亚州对阿片类药物使用障碍的治疗感知能力。
J Appalach Health. 2021 May 3;3(2):32-42. doi: 10.13023/jah.0302.04. eCollection 2021.
6
Overcoming barriers to traditional care delivery and pharmacy challenges: a qualitative study of buprenorphine, telehealth, and a digital therapeutic for opioid use disorder.克服传统护理服务的障碍和药房面临的挑战:丁丙诺啡、远程医疗及一种用于阿片类物质使用障碍的数字疗法的定性研究
Subst Abuse Treat Prev Policy. 2025 Feb 18;20(1):8. doi: 10.1186/s13011-024-00631-9.
7
Medication-Assisted Treatment for Opioid Use Disorder in a Rural Family Medicine Practice.农村家庭医疗实践中的阿片类药物使用障碍药物辅助治疗。
J Prim Care Community Health. 2020 Jan-Dec;11:2150132720931720. doi: 10.1177/2150132720931720.
8
Implications of Increased Access to Buprenorphine for Medical Providers in Rural Areas: A Review of the Literature and Future Directions.农村地区医疗服务提供者获取丁丙诺啡机会增加的影响:文献综述与未来方向
Cureus. 2021 Nov 24;13(11):e19870. doi: 10.7759/cureus.19870. eCollection 2021 Nov.
9
Review of medication-assisted treatment for opioid use disorder.阿片类药物使用障碍的药物辅助治疗综述。
J Osteopath Med. 2022 Mar 14;122(7):367-374. doi: 10.1515/jom-2021-0163.
10
The opioid epidemic in rural communities: Can telehealth increase access to medications for opioid use disorder and offset barriers to care?农村社区的阿片类药物流行:远程医疗能否增加阿片类药物使用障碍药物的可及性并消除护理障碍?
Drug Alcohol Depend. 2025 Jun 1;271:112628. doi: 10.1016/j.drugalcdep.2025.112628. Epub 2025 Mar 1.

本文引用的文献

1
Improving Access to Evidence-Based Medical Treatment for Opioid Use Disorder: Strategies to Address Key Barriers within the Treatment System.改善阿片类物质使用障碍患者获得循证医学治疗的途径:应对治疗系统中关键障碍的策略
NAM Perspect. 2020 Apr 27;2020. doi: 10.31478/202004b. eCollection 2020.
2
Polysubstance use trends and variability among individuals with opioid use disorder in rural versus urban settings.农村与城市环境中阿片类药物使用障碍者的多种物质使用趋势和变异性。
Prev Med. 2021 Nov;152(Pt 2):106729. doi: 10.1016/j.ypmed.2021.106729. Epub 2021 Jul 20.
3
Barriers to accessing opioid substitution treatment for opioid use disorder: A systematic review from the client perspective.
从患者角度看,获取阿片类物质使用障碍类鸦片替代治疗的障碍:系统综述。
Drug Alcohol Depend. 2021 Apr 1;221:108651. doi: 10.1016/j.drugalcdep.2021.108651. Epub 2021 Feb 26.
4
Rural-Urban Differences in Physician Bias Toward Patients With Opioid Use Disorder.城乡医生对阿片类药物使用障碍患者偏见的差异。
Psychiatr Serv. 2021 Aug 1;72(8):874-879. doi: 10.1176/appi.ps.202000529. Epub 2021 Feb 24.
5
Barriers and Facilitators to the Use of Medications for Opioid Use Disorder: a Rapid Review.阿片类物质使用障碍药物治疗的障碍与促进因素:快速综述
J Gen Intern Med. 2020 Dec;35(Suppl 3):954-963. doi: 10.1007/s11606-020-06257-4. Epub 2020 Nov 3.
6
A systematic review of rural-specific barriers to medication treatment for opioid use disorder in the United States.对美国农村地区阿片类药物使用障碍药物治疗的特定障碍进行的系统评价。
Am J Drug Alcohol Abuse. 2020 May 3;46(3):273-288. doi: 10.1080/00952990.2019.1694536. Epub 2019 Dec 6.
7
The role of health insurance on treatment for opioid use disorders: Evidence from the Affordable Care Act Medicaid expansion.医疗保险对阿片类药物使用障碍治疗的作用:平价医疗法案医疗补助扩大的证据。
J Health Econ. 2018 Jul;60:177-197. doi: 10.1016/j.jhealeco.2018.06.004. Epub 2018 Jun 30.
8
Policy Pathways to Address Provider Workforce Barriers to Buprenorphine Treatment.解决美沙酮类物质处方障碍的政策途径。
Am J Prev Med. 2018 Jun;54(6 Suppl 3):S230-S242. doi: 10.1016/j.amepre.2017.12.022.
9
Coverage of Medications That Treat Opioid Use Disorder and Opioids for Pain Management in Marketplace Plans, 2017.医疗保险市场计划中治疗阿片类药物使用障碍和疼痛管理的药物覆盖情况,2017 年。
Med Care. 2018 Jun;56(6):505-509. doi: 10.1097/MLR.0000000000000918.
10
Cost-effectiveness of extended release naltrexone to prevent relapse among criminal justice-involved individuals with a history of opioid use disorder.长效纳曲酮预防有阿片类物质使用障碍病史的刑事司法涉事个体复发的成本效益分析
Addiction. 2017 Aug;112(8):1440-1450. doi: 10.1111/add.13807. Epub 2017 Apr 12.